Early activation of microglia and astrocytes in mouse models of spinocerebellar ataxia type 1
- 1 March 2015
- journal article
- Published by Elsevier in Neuroscience
- Vol. 289, 289-299
Abstract
No abstract availableKeywords
Funding Information
- Institute for the Translational Neuroscience and Minnesota Medical Foundation
- US National Institutes of Health (5RO1NSO045667, 5R37NSO22920)
- National Ataxia Foundation
- Brain Research Foundation
This publication has 51 references indexed in Scilit:
- Salubrinal attenuates β-amyloid-induced neuronal death and microglial activation by inhibition of the NF-κB pathwayNeurobiology of Aging, 2012
- In vivo monitoring of recovery from neurodegeneration in conditional transgenic SCA1 miceExperimental Neurology, 2011
- Vascular endothelial growth factor ameliorates the ataxic phenotype in a mouse model of spinocerebellar ataxia type 1Nature Medicine, 2011
- SCA1-like Disease in Mice Expressing Wild-Type Ataxin-1 with a Serine to Aspartic Acid Replacement at Residue 776Neuron, 2010
- Neurochemical alterations in spinocerebellar ataxia type 1 and their correlations with clinical statusMovement Disorders, 2010
- Suppression of the novel ER protein Maxer by mutant ataxin‐1 in Bergman glia contributes to non‐cell‐autonomous toxicityThe EMBO Journal, 2010
- Inflammation in ALS and SMA: Sorting out the good from the evilNeurobiology of Disease, 2010
- Mechanisms Underlying Inflammation in NeurodegenerationCell, 2010
- Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosisNature Neuroscience, 2008
- The role of LANP and ataxin 1 in E4F‐mediated transcriptional repressionEMBO Reports, 2007